Prices delayed by at least 15 minutes | Print
Astrazeneca PLC (AZN)
ORD SHS $0.25This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Company profile
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
Address
2 Kingdom Street
London
GBR
W2 6BD
Telephone
+44 2076048000
Forecast key dates
Name | Key Date |
---|---|
AstraZeneca PLC First Quarter Earnings Results for 2025 | 2025-04-25T00:00:00 |
AstraZeneca PLC Annual General Meeting for 2025 | 2025-04-11T14:30:00 |
AstraZeneca PLC Annual Report for 2024 | 2025-02-20T00:00:00 |
AstraZeneca PLC Fourth Quarter Earnings Conference Call for 2025 | 2025-02-07T11:45:00 |
AstraZeneca PLC Fourth Quarter Earnings Conference Call for 2024 | 2025-02-07T11:45:00 |
AstraZeneca PLC Fourth Quarter Earnings Results for 2025 | 2025-02-07T00:00:00 |
AstraZeneca PLC Fourth Quarter Earnings Results for 2024 | 2025-02-07T00:00:00 |
AstraZeneca PLC Third Quarter Earnings Results for 2024 | 2024-11-12T00:00:00 |
AstraZeneca PLC Second Quarter Earnings Results for 2024 | 2024-07-25T00:00:00 |
AstraZeneca PLC First Quarter Earnings Results for 2024 | 2024-04-25T00:00:00 |
AstraZeneca PLC Annual General Meeting for 2024 | 2024-04-11T14:30:00 |
Previous key dates
Name | Key Date |
---|---|
AstraZeneca PLC First Quarter Earnings Results for 2024 | 2024-04-25T00:00:00 |
AstraZeneca PLC Annual General Meeting for 2024 | 2024-04-11T14:30:00 |
AstraZeneca PLC Annual Report for 2023 | 2024-02-20T00:00:00 |
AstraZeneca PLC Fourth Quarter Earnings Conference Call for 2023 | 2024-02-08T11:45:00 |
AstraZeneca PLC Fourth Quarter Earnings Result for 2023 | 2024-02-08T00:00:00 |
AstraZeneca PLC Fourth Quarter Earnings Result for 2023 | 2024-02-08T00:00:00 |
AstraZeneca PLC Third Quarter Earnings Results for 2023 | 2023-11-09T00:00:00 |
AstraZeneca PLC Second Quarter Earnings Results for 2023 | 2023-07-28T00:00:00 |
AstraZeneca PLC Annual General Meeting for 2023 | 2023-04-27T14:30:00 |
AstraZeneca PLC First Quarter Earnings Results for 2023 | 2023-04-27T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.